LEADER 03692nam  22006855  450 
001 9911047666703321
005 20251121114905.0
010   $a3-032-09133-0
024 7 $a10.1007/978-3-032-09133-8
035   $a(MiAaPQ)EBC32425674
035   $a(Au-PeEL)EBL32425674
035   $a(CKB)43658944800041
035   $a(DE-He213)978-3-032-09133-8
035   $a(EXLCZ)9943658944800041
100   $a20251121d2026      u|         0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aBehavioral Impact of Cannabinoids /$fedited by Ziva D. Cooper, Sachin Patel, Stephen P. H. Alexander
205   $a1st ed. 2026.
210  1$aCham :$cSpringer Nature Switzerland :$cImprint: Springer,$d2026.
215   $a1 online resource (685 pages)
225 1 $aCurrent Topics in Behavioral Neurosciences,$x1866-3389 ;$v76
311 08$a3-032-09132-2 
327   $aPreface -- Canonical Cannabinoid Receptors -- The pharmacological profile of plant-derived cannabinoids in vitro -- Chemical Probes for Exploiting the Endocannabinoid System -- Genetic Tools in Rodents to Study Cannabinoid Functions -- Pharmacotherapy for Cannabis Use Disorder: Preclinical and Clinical Models -- Delta-9-tetrahydrocannabinol and Cannabidiol for Pain: Preclinical and Clinical Models -- Neurodegeneration and ageing -- Cannabinoid-based pharmacology for the management of drug relapse -- The role of cannabinoids and the endocannabinoid system in the treatment and regulation of nausea and vomiting -- The use of cannabis-based medicine in selected neurological disorders.
330   $aDespite millennia of proximity to, and consumption of products from, the Cannabis plant, we have an incomplete understanding of its behavioural impact. This volume presents current research summaries in three sections, focussing on contextualisation of the work at molecular and cellular levels, and behavioural paradigms for investigating Cannabis and cannabinoid preparations in non-human animals and humans. The contributors are leaders in their respective fields and internationally recognisable. The book contents are unique in the progression that it encompasses the molecular understanding of cannabinoids through animal models of behaviour into humans. It reflects a resurgence in attempts to understand the potential therapeutic benefits of Cannabis and cannabinoid preparations. This is evidenced by the increasing number of countries/states where Cannabis-based products for medicinal use have been approved, as well as some notable locations where non-medicinal consumption of Cannabis preparations has been legalised.
410  0$aCurrent Topics in Behavioral Neurosciences,$x1866-3389 ;$v76
606   $aNeurosciences
606   $aPharmacology
606   $aPain medicine
606   $aPsychiatry
606   $aPsychobiology
606   $aHuman behavior
606   $aNeuroscience
606   $aPharmacology
606   $aPain Medicine
606   $aPsychiatry
606   $aBehavioral Neuroscience
615  0$aNeurosciences.
615  0$aPharmacology.
615  0$aPain medicine.
615  0$aPsychiatry.
615  0$aPsychobiology.
615  0$aHuman behavior.
615 14$aNeuroscience.
615 24$aPharmacology.
615 24$aPain Medicine.
615 24$aPsychiatry.
615 24$aBehavioral Neuroscience.
676   $a612.8
700   $aCooper$b Ziva D$01868436
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9911047666703321
996   $aBehavioral Impact of Cannabinoids$94476348
997   $aUNINA